Discovery & Preclinical
Set a clear product strategy, define a credible clinical and regulatory path, select the right asset and get ready for first-in-human trials with confidence
The growing burden of many neurological conditions such as Alzheimer’s or Parkinson’s disease, multiple sclerosis and chronic pain threatens to overwhelm healthcare resources. While there are many opportunities for new neurological therapeutics, the connections between target and neurological diseases are only slowly being elucidated.
tranScrip’s expertise and capabilities in neurology extend across a wide range of indications such as epilepsy, neurodegenerative diseases, stroke, sleep disorders, depression, schizophrenia, ADHD and pain.
We cover all phases of the product lifecycle and support and guide our clients to meet their targets even if this means challenging the current clinical and regulatory paradigms.
We provide strategic expertise, therapeutic experience and operational excellence across the entire product lifecycle.
Set a clear product strategy, define a credible clinical and regulatory path, select the right asset and get ready for first-in-human trials with confidence
Implement first-in-human trials, interpreting emerging data and adapting plans as needed. Ensure robust decisions, including clear proof-of-concept
Design medically-endorsed pivotal programs that stand up to global regulatory and commercial scrutiny. Navigate issues in implementation
Interpret data, assess benefit/risk and secure regulatory approvals, successfully bring your medicine to market. Ensure strong lifecycle management
Senior Vice President, Clinical Development and External Innovation
Biosplice Therapeutics, Inc.
Get in touch to see how our senior cross-functional experts can help you reduce risk, protect value, and move forward with confidence.
